Impact of Chewing Gum on FeNO Levels in Patients With Bronchial Asthma
NCT07053956 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2025-12-30
Summary
The aim of the study is to investigate the influence of chewing gum consumption on FeNO levels in asthma patients in order to avoid systematic errors in treatment decisions.
Conditions
- Asthma Bronchiale
- FeNO
- Chewing Gum
Interventions
- OTHER
-
Chewing Gum
Patients admitted to our outpatient clinic for bronchial asthma undergo regular FeNO measurements. If the value is ≥ 25 ppb (elevated), the patients are randomized into two groups after obtaining their consent. In the control group, a FeNO measurement is performed again after 15 minutes. In the second group, the FeNO measurement is measured again after 15 minutes of consuming sugar-free, antioxidant-containing chewing gum. The following data are then collected and documented from the patients: age, gender, height, weight, smoking status, current medication, other illnesses, whole body lung function test, and laboratory tests (eosinophils, IgE). Participation in the study will not change the course of the patient's stay in our clinic.
Sponsors & Collaborators
-
RWTH Aachen University
lead OTHER
Principal Investigators
-
Dr. Maria Aetou Aetou · RWTH Aachen University Hospital
-
Professor Michael Dreher Dreher · RWTH Aachen University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- QUADRUPLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-01
- Primary Completion
- 2025-12-17
- Completion
- 2025-12-23
Countries
- Germany
Study Locations
Related Clinical Trials
-
Preventive Medicine Study of Childhood Atopic Diseases
NCT00960596 · Status: UNKNOWN · Phase: NA
- Healthy
-
Smoking Young Asthmatics: Change of Inflammation During Tobacco Cessation and Steroid Treatment
NCT02233231 · Status: COMPLETED · Phase: PHASE4
- Asthma
-
Level of FeNO in Chinese Asthma Patients
NCT04125316 · Status: COMPLETED
- Asthma
-
Assessment of Utility of Exhaled Nitric Oxide Measurement for Treatment Monitoring in Children With Asthma
NCT00500253 · Status: UNKNOWN · Phase: PHASE4
- Asthma
-
Association Between Fractional Exhaled Nitric Oxide and Asthma Control
NCT01197690 · Status: COMPLETED
- Bronchial Asthma
More Related Trials
-
Impact of a Hospital Pharmacist's Intervention on FENO (Fractional Exhaled Nitric Oxide) in Asthmatic Patients
NCT03093363 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Impact of FeNO Assessments on Asthma Management Decisions in Subject 7 to 60 Years of Age
NCT01729247 ·Status: COMPLETED
-
Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting
NCT02640742 ·Status: COMPLETED
-
Correlation Between Fractional Exhaled Nitric Oxide (FeNO) Levels and Asthma Exacerbation
NCT02561351 ·Status: COMPLETED
-
Effects of Regular Submaximal Exercise on Asthma Control and Quality of Life in Patients With Persistent Symptoms
NCT04395937 ·Status: UNKNOWN ·Phase: NA
-
Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study
NCT00263159 ·Status: COMPLETED ·Phase: NA
-
Ex Vivo Effect of Surfactant Protein D on Pulmonary Cells in Patients With Asthma and Pilot Study to Assess Local Inflammation Induced by Segmental Allergen Challenge by Magnetic Resonance Imaging
NCT01378624 ·Status: COMPLETED ·Phase: NA
-
Comparison of Two Methods of Bronchial Methacholine Provocation
NCT00503659 ·Status: COMPLETED ·Phase: NA
-
Fractional Concentration of Exhaled NO(FeNO) to Direct The Treatment of Sub-acute Cough
NCT02655562 ·Status: SUSPENDED ·Phase: PHASE4
-
Development of a Novel Non-invasive Inflammometry Following Allergen Challenge in Patients With Mild Allergic Asthma
NCT06317909 ·Status: RECRUITING ·Phase: NA
-
Association Between Household Health Behaviors and Asthma in Children
NCT04565964 ·Status: UNKNOWN ·Phase: NA
-
A Cohort Study of Smoking Prevention and Health Promotion for Middle School Students in Wuhan, China
NCT00341653 ·Status: COMPLETED
-
Fractional Concentration of Exhaled NO(FENO) to Direct Montelukast Treatment of Sub-acute Cough
NCT02303600 ·Status: UNKNOWN ·Phase: NA
-
A Long-term Safety Study of QMF149 in Japanese Participants With Asthma
NCT03100500 ·Status: COMPLETED ·Phase: PHASE3
-
Influence of a Inhaled Corticosteroid Therapy Versus Corticosteroid + LABA Therapy on the FeNO of Asthmatic Children
NCT00515775 ·Status: COMPLETED
-
Mometasone and Markers of Airway Inflammation
NCT00711165 ·Status: COMPLETED ·Phase: PHASE4
-
Herbal-Based Medication vs. Placebo in Preventing Acute Otitis Media in Children at High Risk of Recurrence
NCT02345447 ·Status: COMPLETED ·Phase: PHASE3
-
Improvement of FeNO and FEF25-75 After Inhaled Corticosteroid Treatment of Asthma
NCT01340118 ·Status: COMPLETED ·Phase: PHASE4
-
Distribution of Neutrophils in Bronchial Mucosal Tissue in Asthma Patients Before and After 4 Weeks Treatment With AZD 5069
NCT01890148 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Toxic Metals, Trace Elements and Total Antioxidant Activity in Children With Recurrent Wheezing
NCT00749528 ·Status: COMPLETED
-
Effects of Allergen Inhalation on Adenosine Receptor Expression in Sputum and Peripheral Blood
NCT00116311 ·Status: UNKNOWN
-
Safety and Efficacy Study of OC000459 Dosed Twice Daily for 28 Days in Asthmatic Subjects
NCT01057927 ·Status: COMPLETED ·Phase: PHASE2
-
Real Life Experience Survey of Dupilumab in the Netherlands
NCT05331755 ·Status: COMPLETED
-
Study of Inhaled Glucocorticosteroid Administration in Asthma Patients
NCT00559689 ·Status: COMPLETED
-
Prospective Study of the Feedback From an Adherence Monitor on Asthma Control
NCT01529697 ·Status: COMPLETED ·Phase: NA